Pain Therapeutics reported $-20257000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US USD 1.44B 583M
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Amgen AMGN:US USD 2.14B 826M
Biogen BIIB:US USD 1.13B 76.7M
Cara Therapeutics CARA:US USD -23180000 18.97M
Eisai 4523:JP JPY 3.57B 23.33B
Eli Lilly And LLY:US USD 1.45B 499.2M
Johnson & Johnson JNJ:US USD 4.46B 356M
Merk MRK:US USD 3.25B 696M
Novartis NOVN:VX USD 1.57B 121M
Pain Therapeutics PTIE:US USD -20257000 929K
Pfizer PFE:US USD 8.61B 1.3B